Marathon Petroleum Corp (MPC) moved up by 3.10%. The Energy - Fossil Fuels sector is up by 2.23%. The company outperformed the industry. Top 3 stocks by turnover in the sector: BP PLC (BP) up 3.19%; Exxon Mobil Corp (XOM) up 1.34%; Chevron Corp (CVX) up 2.85%.

Marathon Petroleum Corp. (MPC) experienced an upward movement on April 2, 2026, driven primarily by significant macroeconomic and geopolitical factors impacting the energy sector. A key catalyst was the sharp increase in crude oil prices, with both West Texas Intermediate and Brent benchmarks seeing substantial gains. This surge was attributed to escalating geopolitical tensions and concerns over potential supply disruptions, which often bolster the profitability outlook for integrated refiners.
In the days leading up to and on April 2, sentiment surrounding MPC was also buoyed by positive adjustments from equity analysts. Multiple firms increased their price targets for the company while maintaining favorable ratings such as "Buy" or "Overweight." This demonstrated a growing confidence in Marathon Petroleum's financial performance and future prospects from the investment community.
The broader market context also played a role, as shares of oil companies generally rose amidst the geopolitical uncertainty and rising commodity prices, even as the wider market experienced some pressure. For a company like Marathon Petroleum, with its significant refining operations, a tightening supply outlook for crude and refined products can lead to improved refining margins, contributing positively to its share price performance.
Technically, Marathon Petroleum Corp (MPC) shows a MACD (12,26,9) value of [10.91], indicating a neutral signal. The RSI at 59.37 suggests neutral condition and the Williams %R at -57.70 suggests oversold condition. Please monitor closely.
Marathon Petroleum Corp (MPC) is in the Energy - Fossil Fuels industry. Its latest annual revenue is $133.43B, ranking 6 in the industry. The net profit is $4.04B, ranking 13 in the industry. Company Profile

Over the past month, multiple analysts have rated the company as Buy, with an average price target of $216.06, a high of $299.00, and a low of $168.94.
Company Specific Risks: